![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsored by: |
AstraZeneca |
---|---|
Information provided by: | AstraZeneca |
ClinicalTrials.gov Identifier: | NCT00503061 |
To investigate how common it is that patients using Symibort SMART take high average daily doses that are not considered appropriate by their physician (overuse) or are hospitalised due to their asthma at least partly due to underuse.
Condition |
---|
Bronchial Asthma |
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Official Title: | A Pharmaceopidemiological Study in Patients Who Use Symbicort Turbuhaler as Maintenance and Reliever Therapy (Symibort SMART) Capturing Over Use and Under Use Via the General Practice Research Database |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: AstraZeneca Clinical Study, Information | 1-800-236-9933 | information.center@astrazeneca.com |
Contact: AstraZeneca Information (Outside, US) | 001-800-236-9933 |
United Kingdom | |
Research Site | Recruiting |
London, United Kingdom |
Principal Investigator: | Catriona McMahon, MD | AZ UK MC |
Study Director: | Tomas Andersson, MD | AZ R&D Lund |
Study ID Numbers: | D5890C00017, GPRD |
Study First Received: | July 17, 2007 |
Last Updated: | April 3, 2009 |
ClinicalTrials.gov Identifier: | NCT00503061 History of Changes |
Health Authority: | United Kingdom: Independent Scientific Advisory Committee |
pharmaceopidemiological Symbicort SMART GPRD |
Hypersensitivity Lung Diseases, Obstructive Symbicort Respiratory Tract Diseases Bronchial Diseases |
Lung Diseases Hypersensitivity, Immediate Anti-Asthmatic Agents Asthma Respiratory Hypersensitivity |
Respiratory System Agents Bronchial Diseases Immune System Diseases Symbicort Asthma Anti-Asthmatic Agents Pharmacologic Actions |
Lung Diseases, Obstructive Hypersensitivity Respiratory Tract Diseases Lung Diseases Therapeutic Uses Hypersensitivity, Immediate Respiratory Hypersensitivity |